1. Home
  2. LEGN vs LKQ Comparison

LEGN vs LKQ Comparison

Compare LEGN & LKQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • LKQ
  • Stock Information
  • Founded
  • LEGN 2014
  • LKQ 1998
  • Country
  • LEGN United States
  • LKQ United States
  • Employees
  • LEGN N/A
  • LKQ N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • LKQ Motor Vehicles
  • Sector
  • LEGN Health Care
  • LKQ Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • LKQ Nasdaq
  • Market Cap
  • LEGN 9.1B
  • LKQ 10.4B
  • IPO Year
  • LEGN 2020
  • LKQ 2003
  • Fundamental
  • Price
  • LEGN $38.19
  • LKQ $38.20
  • Analyst Decision
  • LEGN Strong Buy
  • LKQ Strong Buy
  • Analyst Count
  • LEGN 13
  • LKQ 6
  • Target Price
  • LEGN $81.46
  • LKQ $55.83
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • LKQ 2.6M
  • Earning Date
  • LEGN 11-12-2024
  • LKQ 10-24-2024
  • Dividend Yield
  • LEGN N/A
  • LKQ 3.14%
  • EPS Growth
  • LEGN N/A
  • LKQ N/A
  • EPS
  • LEGN N/A
  • LKQ 2.67
  • Revenue
  • LEGN $520,183,000.00
  • LKQ $14,499,000,000.00
  • Revenue This Year
  • LEGN $110.04
  • LKQ $5.13
  • Revenue Next Year
  • LEGN $77.16
  • LKQ $1.42
  • P/E Ratio
  • LEGN N/A
  • LKQ $14.15
  • Revenue Growth
  • LEGN 122.96
  • LKQ 8.48
  • 52 Week Low
  • LEGN $38.02
  • LKQ $35.57
  • 52 Week High
  • LEGN $70.13
  • LKQ $53.68
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 29.40
  • LKQ 47.76
  • Support Level
  • LEGN $38.94
  • LKQ $37.84
  • Resistance Level
  • LEGN $41.87
  • LKQ $39.40
  • Average True Range (ATR)
  • LEGN 2.20
  • LKQ 0.69
  • MACD
  • LEGN -0.30
  • LKQ 0.17
  • Stochastic Oscillator
  • LEGN 1.74
  • LKQ 56.04

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About LKQ LKQ Corporation

Since forming in 1998 to consolidate the auto salvage business in the United States, LKQ has developed into a leading distributor of aftermarket and recycled auto parts with around 1,700 facilities across North America and Europe. The company primarily sells into the professional, or do-it-for-me, channel and offers an assortment of collision and mechanical parts to both body shops and mechanical repair shops. It also continues to operate more than 70 LKQ pick-your-part junkyards. Separate from the self-service business, LKQ typically purchases around 250,000 salvage vehicles annually that are used to extract vehicle parts for resale.

Share on Social Networks: